Nasdaq trade halt: news pending at 7:50 p.m.
XXII•Trading in 22nd Century Group was halted pending news at 7:50 p.m.
Related News
HUTCHMED's sovleplenib gets FDA orphan drug designation for autoimmune hemolytic anemia
HCM•
Immutep plans presentation of final survival data from head and neck cancer trial in December
IMMP•
Stoneridge Q3 net loss widens
SRI•
Capital One announces quarterly dividend of $0.80 per common share
COF•
McGrath RentCorp CFO Keith E. Pratt reports $2.55 million share sale
MGRC•